Current issues in uncomplicated skin and skin structure infections

References

• Rosen T. Update on treating uncomplicated skin and skin structure infections. J. Drugs Dermatol.4(Suppl. 6), S9–S14 (2005).
   Google Scholar
• Breneman DL. Use of mupirocin ointment in the treatment of secondarily infected dermatoses. J. Am. Acad. Dermatol.22(5 Pt 1), 886–892 (1990).
   PubMed Web of Science ®Google Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch. Dermatol.113(6), 780–782 (1977).
   PubMedGoogle Scholar
• Foster TJ. The Staphylococcus aureus ‘superbug’. J. Clin. Invest.114(12), 1693–1696 (2004).
   PubMed Web of Science ®Google Scholar
• Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol.9(12), 605–610 (2001).
   PubMed Web of Science ®Google Scholar
• von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N. Engl. J. Med.344(1), 11–16 (2001).
   PubMed Web of Science ®Google Scholar
• Mainous AG 3rd, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001–2002. Ann. Fam. Med.4(2), 132–137 (2006).
   PubMed Web of Science ®Google Scholar
• White MI, Noble WC. Consequences of colonization and infection by Staphylococcus aureus in atopic dermatitis. Clin. Exp. Dermatol.11(1), 34–40 (1986).
   PubMed Web of Science ®Google Scholar
• Perera G, Hay R. A guide to antibiotic resistance in bacterial skin infections. J. Eur. Acad. Dermatol. Venereol.19(5), 531–545 (2005).
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bisno AL, Chambers HF et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis.41(10), 1373–1406 (2005).
   PubMed Web of Science ®Google Scholar
• Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J. Am. Acad. Dermatol.20(3), 367–390 (1989).
   PubMed Web of Science ®Google Scholar
• Mangram AJ. A brief overview of the 1999 CDC Guideline for the Prevention of Surgical Site Infection. Centers for Disease Control and Prevention. J. Chemother. 13 Spec No 1(1), 35–39 (2001).
   Google Scholar
• Lowell BA, Froelich CW, Federman DG, Kirsner RS. Dermatology in primary care: prevalence and patient disposition. J. Am. Acad. Dermatol.45(2), 250–255 (2001).
   PubMed Web of Science ®Google Scholar
• Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly NK. Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian J. Med. Res.95, 234–238 (1992).
   PubMed Web of Science ®Google Scholar
• Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect. Dis.5(8), 501–513 (2005).
   PubMed Web of Science ®Google Scholar
• Bikowski J. Secondarily infected wounds and dermatoses: a diagnosis and treatment guide. J. Emerg. Med.17(1), 197–206 (1999).
   PubMed Web of Science ®Google Scholar
• Elek SD. Experimental staphylococcal infections in the skin of man. Ann. NY Acad. Sci.65(3), 85–90 (1956).
   PubMed Web of Science ®Google Scholar
• Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv. Dermatol.21, 357–374 (2005).
   PubMedGoogle Scholar
• Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J. Invest. Dermatol.125(1), 9–13 (2005).
   PubMed Web of Science ®Google Scholar
• Stevens T, Johnson B, Bouchillon S et al. A multi-center global surveillance study of the in vitro activity of retapamulin (SB-275833), a novel topical pleuromutilin against 2,939 clinical isolates of S. aureus and coagulase negative staphylococci from uncomplicated skin and skin structure infections (SSSIs). 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington DC, USA F-2062 (2005).
   Google Scholar
• Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med. J.47(3), 293–306 (2006).
   PubMed Web of Science ®Google Scholar
• Braff MH, Gallo RL. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol.306, 91–110 (2006).
   PubMed Web of Science ®Google Scholar
• Carretero M, Del Rio M, Garcia M et al. A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J.18(15), 1931–1933 (2004).
   PubMed Web of Science ®Google Scholar
• Sieprawska-Lupa M, Mydel P, Krawczyk K et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother.48(12), 4673–4679 (2004).
   PubMed Web of Science ®Google Scholar
• Fedtke I, Gotz F, Peschel A. Bacterial evasion of innate host defenses – the Staphylococcus aureus lesson. Int. J. Med. Microbiol.294(2–3), 189–194 (2004).
   PubMed Web of Science ®Google Scholar
• Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun.72(12), 7107–7114 (2004).
   PubMed Web of Science ®Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev.13(1), 16–34 (2000).
   PubMed Web of Science ®Google Scholar
• Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis.29(5), 1128–1132 (1999).
   PubMed Web of Science ®Google Scholar
• Voyich JM, Otto M, Mathema B et al. Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis.194(12), 1761–1770 (2006).
   PubMed Web of Science ®Google Scholar
• Chaussee MS, Somerville GA, Reitzer L, Musser JM. Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J. Bacteriol.185(20), 6016–6024 (2003).
   PubMed Web of Science ®Google Scholar
• Tamura F, Nakagawa R, Akuta T et al. Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect. Immun.72(8), 4836–4847 (2004).
   PubMed Web of Science ®Google Scholar
• Bricker AL, Cywes C, Ashbaugh CD, Wessels MR. NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol. Microbiol.44(1), 257–269 (2002).
   PubMed Web of Science ®Google Scholar
• Hedrick J. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment. Paediatr. Drugs5(Suppl.) 135–146 (2003).
   Google Scholar
• Koning S, van Belkum A, Snijders S et al. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton–Valentine leukocidin, and the multidrug resistance plasmid pSK41. J. Clin. Microbiol.41(7), 3017–3021 (2003).
   PubMed Web of Science ®Google Scholar
• Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr. Dermatol.11(4), 293–303 (1994).
   PubMed Web of Science ®Google Scholar
• Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol.105(5), 860–876 (2000).
   PubMed Web of Science ®Google Scholar
• Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am. Fam. Physician66(1), 119–124 (2002).
   PubMed Web of Science ®Google Scholar
• Sladden MJ, Johnston GA. More common skin infections in children. Br. Med. J.330(7501), 1194–1198 (2005).
   PubMedGoogle Scholar
• Mancini AJ. Bacterial skin infections in children: the common and the not so common. Pediatr. Ann.29(1), 26–35 (2000).
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association ‘Administrative Regulations for Evidence-Based Clinical Practice Guidelines’. J. Am. Acad. Dermatol.50(3), 391–404 (2004).
   PubMed Web of Science ®Google Scholar
• Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol. Allergy Clin. North Am.2, 21–24 (2002).
   Google Scholar
• Lewis-Jones S. Atopic dermatitis in childhood. Hosp. Med.62(3), 136–143 (2001).
   PubMed Web of Science ®Google Scholar
• Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J. Am. Acad. Dermatol.53(1), 67–72 (2005).
   PubMed Web of Science ®Google Scholar
• Christophers E, Henseler T. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch. Dermatol. Res.279(Suppl.) S48–51 (1987).
   Google Scholar
• Grice K, Sattar H, Baker H, Sharratt M. The relationship of transepidermal water loss to skin temperature in psoriasis and eczema. J. Invest. Dermatol.64(5), 313–315 (1975).
   PubMed Web of Science ®Google Scholar
• Emmett EA. Occupational skin disease. J. Allergy Clin. Immunol.72(6), 649–656 (1983).
   PubMed Web of Science ®Google Scholar
• Baker BS. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol.144(1), 1–9 (2006).
   PubMed Web of Science ®Google Scholar
• Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J. Allergy Clin. Immunol.108(2), 269–274 (2001).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med.347(15), 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY. Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J. Invest. Dermatol.116(5), 658–663 (2001).
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F, Giustizieri ML, Giannetti A, Girolomoni G. Pathogenetic mechanisms of atopic dermatitis. Arch. Immunol. Ther. Exp. (Warsz).48(6), 497–504 (2000).
   PubMedGoogle Scholar
• Esche C, de Benedetto A, Beck LA. Keratinocytes in atopic dermatitis: inflammatory signals. Curr. Allergy Asthma Rep.4(4), 276–284 (2004).
   PubMed Web of Science ®Google Scholar
• Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J. Invest. Dermatol.115(3), 406–413 (2000).
   PubMed Web of Science ®Google Scholar
• Imokawa G. Lipid abnormalities in atopic dermatitis. J. Am. Acad. Dermatol.45(Suppl. 1), S29–S32 (2001).
   PubMed Web of Science ®Google Scholar
• Breuhahn K, Mann A, Muller G et al. Epidermal overexpression of granulocyte–macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell Growth Differ.11(2), 111–121 (2000).
   PubMedGoogle Scholar
• Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol.171(6), 3262–3269 (2003).
   PubMed Web of Science ®Google Scholar
• Melnik B. [Disturbances of antimicrobial lipids in atopic dermatitis]. J. Dtsch Dermatol. Ges.4(2), 114–123 (2006).
   PubMedGoogle Scholar
• Higaki S, Nakamura M, Yoshida I, Morohashi M. Secondary infections with β-hemolytic streptococci in skin lesions. Int. J. Tissue React.25(2), 47–50 (2003).
   PubMedGoogle Scholar
• Raychaudhuri SP, Jiang WY, Raychaudhuri SK, Krensky AM. Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin. J. Am. Acad. Dermatol.51(6), 1006–1008 (2004).
   PubMed Web of Science ®Google Scholar
• de Jongh GJ, Zeeuwen PL, Kucharekova M et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol.125(6), 1163–1173 (2005).
   PubMed Web of Science ®Google Scholar
• Thorell E, Jackson M, Bratcher D, Swanson D, Selvarangan R. Antimicrobial resistance of Staphylococcus aureus from Kansas City children: what is the appropriate current therapy for pediatric staphylococcal infections? 42nd Annual Meeting of the Infectious Diseases Society of America. MA, USA 81 (2004) (Abstract 252).
   Google Scholar
• Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev.14(2), 244–269 (2001).
   PubMed Web of Science ®Google Scholar
• Darmstadt GL. Oral antibiotic therapy for uncomplicated bacterial skin infections in children. Pediatr. Infect. Dis. J.16(2), 227–240 (1997).
   PubMed Web of Science ®Google Scholar
• Williford PM. Opportunities for mupirocin calcium cream in the emergency department. J. Emerg. Med.17(1), 213–220 (1999).
   PubMed Web of Science ®Google Scholar
• Rist T, Parish LC, Capin LR, Sulica V, Bushnell WD, Cupo MA. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. Clin. Exp. Dermatol.27(1), 14–20 (2002).
   PubMed Web of Science ®Google Scholar
• Kraus SJ, Eron LJ, Bottenfield GW, Drehobl MA, Bushnell WD, Cupo MA. Mupirocin cream is as effective as oral cephalexin in the treatment of secondarily infected wounds. J. Fam. Pract.47(6), 429–433 (1998).
   PubMed Web of Science ®Google Scholar
• Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics115(4), 1048–1057 (2005).
   PubMed Web of Science ®Google Scholar
• Fonacier L, Hirschberg R, Gerson S. Adverse drug reactions to a cephalosporins in hospitalized patients with a history of penicillin allergy. Allergy Asthma Proc.26(2), 135–141 (2005).
   PubMed Web of Science ®Google Scholar
• Antunez C, Blanca-Lopez N, Torres MJ et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J. Allergy Clin. Immunol.117(2), 404–410 (2006).
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J. Fam. Pract.55(2), 106–112 (2006).
   PubMed Web of Science ®Google Scholar
• Rayner C, Munckhof WJ. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern. Med. J.35(Suppl.2) S3–S16 (2005).
   PubMed Web of Science ®Google Scholar
• Scher RK, Elston DM, Hedrick JA, Joseph WS, Maurer T, Murakawa GJ. Treatment options in the management of uncomplicated skin and skin structure infections. Cutis75(Suppl. 1), 3–23 (2005).
   PubMed Web of Science ®Google Scholar
• Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg. Infect. Dis.11(6), 928–930 (2005).
   PubMed Web of Science ®Google Scholar
• Bouchillon S, Johnston GA, Stevens T et al. Methicillin- and mupirocin-resistance in community-associated S. aureus obtained from uncomplicated skin and skin structure infections (SSSIs) in the United States in 2004–2005; Retapamulin surveillance study. 43rd Infectious Diseases Society of America. San Francisco, CA, USA, October 6–9 2005.
   Google Scholar
• Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int. J. Antimicrob. Agents22(4), 406–419 (2003).
   PubMed Web of Science ®Google Scholar
• Richter SS, Heilmann KP, Beekmann SE et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin. Infect. Dis.41(5), 599–608 (2005).
   PubMed Web of Science ®Google Scholar
• Appelbaum PC. MRSA – the tip of the iceberg. Clin. Microbiol. Infect.12(Suppl.2) 3–10 (2006).
   PubMed Web of Science ®Google Scholar
• Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton–Valentine leucocidin. J. Clin. Microbiol.42(5), 2080–2084 (2004).
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis.40(12), 1785–1791 (2005).
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int. J. Antimicrob. Agents27(2), 87–96 (2006).
   PubMed Web of Science ®Google Scholar
• McClure JA, Conly JM, Lau V et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton–Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J. Clin. Microbiol.44(3), 1141–1144 (2006).
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis.9(8), 978–984 (2003).
   PubMed Web of Science ®Google Scholar
• Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet367(9512), 731–739 (2006).
   PubMed Web of Science ®Google Scholar
• King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med.144(5), 309–317 (2006).
   PubMed Web of Science ®Google Scholar
• Fritsche TR, Jones RN. Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus. J. Drugs Dermatol.4(Suppl. 6), S4–S8 (2005).
   Google Scholar
• Kollef MH, Micek ST. Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? Curr. Opin. Infect. Dis.19(2), 161–168 (2006).
   PubMed Web of Science ®Google Scholar
• Ruhe JJ, Monson TP. Use of tetracyclines for infections caused by methicillin-resistant Staphylococcus aureus. 42nd Annual Meeting of the Infectious Diseases Society of America. MA, USA 139 (2004).
   Google Scholar
• Elston DM. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm. J. Drugs Dermatol.4(Suppl. 6), S15–S19 (2005).
   Google Scholar
• Gales AC, Andrade SS, Sader HS, Jones RN. Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program. J. Chemother.16(4), 323–328 (2004).
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Fix AM, Pfaller MA, Jones RN. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn. Microbiol. Infect. Dis.42(4), 283–290 (2002).
   PubMed Web of Science ®Google Scholar
• Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect. Control. Hosp. Epidemiol.24(5), 342–346 (2003).
   PubMed Web of Science ®Google Scholar
• Mason BW, Howard AJ. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case–control study. Int. J. Antimicrob. Agents23(3), 300–303 (2004).
   PubMed Web of Science ®Google Scholar
• Brown EM, Wise R. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint. Br. Med. J.324(7350), 1394 (2002).
   Google Scholar
• Del Giudice P, Blanc V, Durupt F et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br. J. Dermatol.154(1), 118–124 (2006).
   PubMed Web of Science ®Google Scholar
• Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis.36(Suppl. 1), S11–S23 (2003).
   PubMed Web of Science ®Google Scholar
• Livermore DM. Can β-lactams be re-engineered to beat MRSA? Clin. Microbiol. Infect.12(Suppl.) 211–216 (2006).
   Google Scholar
• Akins RL, Haase KK. Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy25(7), 1001–1010 (2005).
   PubMed Web of Science ®Google Scholar
• Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis.42(5), 657–668 (2006).
   PubMed Web of Science ®Google Scholar
• Free A, Roth E, Dalessandro M et al. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. SkinMed5, 224–232 (2006).
   PubMedGoogle Scholar
• Parish LC, Jorizzo JL, Breton JJ et al. Efficacy and safety of topical retapamulin ointment (1%, w/w) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily-infected dermatitis: results of a randomized, controlled, trial. J. Am. Acad. Dermatol.55(6), 1006–1016 (2006).
   Google Scholar
• Hunt E. Pleuromutilin antibiotics. Drugs Fut.25(11), 1163–1168 (2000).
   Web of Science ®Google Scholar
• Thornton Spann C, Taylor SC, Weinberg JM. Topical antimicrobial agents in dermatology. Clin. Dermatol.21(1), 70–77 (2003).
   PubMed Web of Science ®Google Scholar
• Heggers JP, Sazy JA, Stenberg BD et al. Bactericidal and wound-healing properties of sodium hypochlorite solutions: the 1991 Lindberg Award. J. Burn Care Rehabil.12(5), 420–424 (1991).
   PubMedGoogle Scholar
• Bikowski J. Secondarily infected wounds and dermatoses: a diagnosis and treatment guide. The Journal of Emergency Medicine.17, 198 (1999).
   Web of Science ®Google Scholar